HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

6H,6- (2- (dimethylamino)ethoxycarbonyl)dibenzo(b,d)pyran

RN given refers to the HCl; RN for parent cpd not available 6/91

Also Known As:

FCE 20696; FCE-20696

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - 6H,6-(2-(dimethylamino)ethoxycarbonyl)dibenzo(b,d)pyran: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - 6H,6-(2-(dimethylamino)ethoxycarbonyl)dibenzo(b,d)pyran: 2

Related Diseases

1.	Autoimmune Diseases (Autoimmune Disease) 01/01/1991 - "Effects of the new immunoactive compound FCE 20696 on rat and murine models of autoimmune diseases." 12/01/1986 - "FCE 20696 is a new synthetic immunomodulating agent, active on some manifestations of the autoimmune disease of NZB/WF1 mice, in which a disorder of T suppressor cells (SC) has been described to be of pathogenetic relevance. "
2.	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/01/1991 - "Experimental Allergic Encephalomyelitis (EAE) has been induced in rats and FCE 20696 has been given for two weeks before the encephalitogenic stimulus and continued afterwards until the complete recovery. "
3.	Experimental Arthritis 01/01/1991 - "Adjuvant Arthritis (AA) has been induced in rats and FCE 20696 has been given for five weeks starting one week before the induction of the disease. "